One pathway implicated in PDGFRβ regulation is MYC, a transcriptional repressor of PDGFRβ, hence blocking ERK1/2-dependent MYC signaling induces expression and activation of PDGFRβ in breast cancer [37]. Here, MAPK3 is linked to breast carcinoma.